Cedar Brook Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,035
| Closed | -$602K | – | 367 |
|
|
2024
Q1 | $602K | Buy |
1,035
+25
| +2% | +$14.5K | 0.12% | 181 |
|
|
2023
Q4 | $551K | Buy |
1,010
+388
| +62% | +$212K | 0.12% | 181 |
|
|
2023
Q3 | $315K | Sell |
622
-79
| -11% | -$40K | 0.08% | 246 |
|
|
2023
Q2 | $365K | Sell |
701
-25
| -3% | -$13K | 0.09% | 239 |
|
|
2023
Q1 | $419K | Buy |
726
+24
| +3% | +$13.8K | 0.11% | 205 |
|
|
2022
Q4 | $387K | Sell |
702
-19
| -3% | -$10.5K | 0.11% | 209 |
|
|
2022
Q3 | $366K | Buy |
721
+38
| +6% | +$19.3K | 0.12% | 207 |
|
|
2022
Q2 | $371K | Buy |
683
+88
| +15% | +$47.8K | 0.12% | 204 |
|
|
2022
Q1 | $351K | Buy |
595
+59
| +11% | +$34.8K | 0.09% | 237 |
|
|
2021
Q4 | $357K | Buy |
536
+34
| +7% | +$22.6K | 0.09% | 242 |
|
|
2021
Q3 | $287K | Sell |
502
-34
| -6% | -$19.4K | 0.09% | 255 |
|
|
2021
Q2 | $271K | Buy |
536
+43
| +9% | +$21.7K | 0.08% | 292 |
|
|
2021
Q1 | $225K | Sell |
493
-6
| -1% | -$2.74K | 0.08% | 287 |
|
|
2020
Q4 | $232K | Sell |
499
-66
| -12% | -$30.7K | 0.08% | 277 |
|
|
2020
Q3 | $249K | Sell |
565
-4
| -0.7% | -$1.76K | 0.1% | 234 |
|
|
2020
Q2 | $206K | Buy |
+569
| New | +$206K | 0.09% | 258 |
|